The global hypertensive heart diseases market is anticipated to grow at a CAGR of around 3.5% during the forecast period (2021-2027). Hypertensive heart diseases refer to heart failure, CAD (coronary artery disease), and thickening of heart muscles, due to high blood pressure. Other diseases caused by high blood pressure include stroke, ischemic heart disease, peripheral artery disease, aneurysms, and other kidney diseases. The rising prevalence of hypertensive heart diseases & awareness program by government organizations, and high global healthcare expenditure is boosting the growth of hypertensive heart disease market. According to the American College of Cardiology, Cardiovascular disease (CVD) are the leading cause of death in the US, around 840,768 deaths (635,260 cardiac) in 2016 were due to CVDs. Whereas, according to the same source, every 40 seconds on an average, an American will have a stroke. About 795,000 Americans have a new or recurrent stroke annually. The high healthcare expenditure by the government is also playing an important role in the market growth. For instance, in 2018, $3.8 trillion were invested by the US government in healthcare, under which $194 billion or 5% of the healthcare spending has been invested in medical and R&D expenditure. The federal government contributed around 22.2% to Medical and Health R&D expenditures.
To Request a Sample of our Report on Hypertensive Heart Disease Market: https://www.omrglobal.com/request-sample/hypertensive-heart-disease-market
Additionally, rising medical tourism in emerging economies such as China, Thailand, and India, are some factors driving the market growth. The global hypertensive heart disease market is segmented into diagnosis and therapeutics. Moreover, the high cost of diagnostics and therapeutics technologies, side effects of hypertensive drugs, and strict government policies are restraining the global hypertensive heart disease market. The introduction of pipeline products for the treatment of hypertensive disorders is one of the major opportunities anticipated to propel market growth in the near future.
(Get 15% Discount on Buying this Report)
A full Report of Hypertensive Heart Disease Market is Available at: https://www.omrglobal.com/industry-reports/hypertensive-heart-disease-market
Global Hypertensive Heart Disease Market Segmentation
By Diagnosis
· Electrocardiogram
· Echocardiogram
· Coronary Angiography
· Others (Chest X-Ray)
By Therapeutics
· Drugs
· Thiazide Diuretics
· Beta-Blockers
· Angiotensin-Converting Enzyme (ACE) Inhibitors
· Angiotensin II Receptor Blockers (ARB)
· Calcium Channel Blockers
· Others (Renin Inhibitors)
· Surgery
· Coronary Artery Bypass Surgery
· Transmyocardial Laser Revascularization
· Heart Transplant
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
